Deutsche Bank
DGX icon

Deutsche Bank’s Quest Diagnostics DGX Stock Holding History

Deutsche Bank’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-40
Closed -$5K – 4166
2022
Q1 		$5K Buy
+40
New +$5.58K ﹤0.01% 4161

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Deutsche Bank's DGX Position: Q1 2026 in Review

Deutsche Bank reduced its Quest Diagnostics (DGX) stake by 9.6% in Q1 2026, selling an estimated $11.3M and leaving 550,899 shares worth $108M. The position accounts for 0.04% of the portfolio, ranked #456.

Deutsche Bank first reported a position in DGX in Q2 2013 and has held it in 52 quarters since. The position peaked at $142M in Q1 2015. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Deutsche Bank held 550,899 shares of Quest Diagnostics worth $108M as of Q1 2026.
  • Deutsche Bank sold 58,182 Quest Diagnostics shares in Q1 2026, an estimated $11.3M.
  • Quest Diagnostics made up 0.04% of Deutsche Bank's portfolio in Q1 2026, its #456 holding.
  • Deutsche Bank first reported a position in Quest Diagnostics in Q2 2013 and has held it in 52 quarters since.
  • Deutsche Bank's Quest Diagnostics position peaked at $142M in Q1 2015.
  • 1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.